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Hemophagocytic lymphohistiocytosis (HLH) has been
described in patients with advanced stages of human immu-
nodeficiency virus (HIV) infection, but rarely occurs during
the seroconversion stage of acute HIV infection. We report a
case of acute HIV syndrome that presented with virus-asso-
ciated HLH. The patient recovered spontaneously without
any immunomodulating therapy. This case suggests that
acute HIV infection should be included in the differential
diagnosis of HLH and indicates that HLH associated with
acute HIV infection can have a favorable outcome.
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INTRODUCTION
Hemophagocytic lymphohistiocytosis (HLH)
has been described in association with a number
of viral diseases, including human immunodefici-
ency virus (HIV) infection.
1-3 Most of the HLH
cases diagnosed in HIV patients have been iden-
tified in patients with advanced stages of HIV
infection and were often found in association with
concomitant infections or malignant disease.
These patients have a reported 21% recovery rate,
which suggests that HIV patients with HLH have
a poor prognosis.
Acute HIV infection is defined as the period
from the initial HIV infection to complete
seroconversion. More than 90% of acute infections
go undiagnosed and only 50% of acute HIV cases
are symptomatic.
4 This infection period is asso-
ciated with high levels of viremia, and the clinical
manifestations are variable. HLH caused by acute
HIV infection alone has not been reported very
frequently. Here, we describe the first case of
HLH during the acute stage of HIV infection in
a Korean patient. The patient recovered sponta-
neously without any immunomodulating therapy.
CASE REPORT
A 44-year-old heterosexual man visited our
hospital after experiencing 3 weeks of fever, chills,
sore throat, generalized malaise, myalgia, and
anorexia. This patient had no medical history,
except for syphilis, which had been treated 10
years previously. The patient had not been an
intravenous drug user and denied having any risk
behaviors for HIV infection, except for one in-
cident of sexual intercourse with a man 1 month
before presentation. Upon physical examination,
the patient appeared acutely ill and had a tem-
perature of 38.7 , a respiratory rate of 16 breaths/
min, and a pulse of 66 beats/min. The patient also
had icteric sclera, enlarged tonsils coated with
purulent exudates, and multiple, pea-sized,
non-tender lymph nodes involving the superficial
and deep cervical nodes bilaterally. A non-pruritic
morbilliform erythematous rash was present on
the trunk and extremities.
Laboratory values were determined as follows:
WBC count; 3,900 cells/ L with 24% neutrophils μ
and 50% lymphocytes (4,800 - 10,800 cells/ L; μ
reference values in parentheses), hemoglobin; 13.6
g/dL (12 - 18 g/dL), hematocrit; 40% (37 - 52%),
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platelet count; 90 × 10
3/ L (130 μ - 450 × 10
3/ L), μ
alanine aminotransferase; 869 U/L (< 37 U/L),
aspartate aminotransferase; 494 U/L (< 37 U/L),
lactate dehydrogenase; 8,400 U/L (< 37 U/L),
alkaline phosphatase; 1,147 U/L (32 - 117 U/L),
total bilirubin; 6.6 mg/dL (<0.6 mg/dL), direct
bilirubin; 6.2 mg/dL (< 0.3 mg/dL), total protein;
6.6 g/dL (6 - 8.3 g/dL), albumin; 3.0 g/dL (3.5 - 5
g/dL), total cholesterol; 146 mg/dL (< 200 mg/
dL), triglycerides; 480 mg/dL (< 200 mg/dL),
LDL-cholesterol; 23 mg/dL (< 120 mg/dL), HDL-
cholesterol; 11.6 mg/dL (40 - 80 mg/dL), ferritin; >
30,000 ng/mL (7 - 323 ng/mL), ESR 11; mm/h (<
20 mm/h), CRP; 0.63 mg/dL (< 1 mg/dL), pro-
thrombin time; 10.4 s (< 11.5 s), aPTT; 54.7 s (26-
41 s), FDP; 20 g/mL (< μ 5 g/mL), D-dimer; 1.7 μ
mg/L (< 0.3 mg/L), and fibrinogen; 178 mg/ dL
(200 - 485 mg/dL).
The patient's chest X-ray was unremarkable
with no identified focus of infection. Multiple,
deep, homogenous enhancements of the lymph
nodes were noted in the neck by computed
tomography (CT). The abdominal ultrasound and
CT demonstrated mild hepatomegaly and acal-
culous gallbladder thickening with a normal bile
duct. A fine needle aspiration biopsy of a cervical
lymph node was compatible with a diagnosis of
necrotizing lymphadenitis. A bone marrow as-
piration and biopsy were also performed.
Pathological examination of the bone marrow
revealed normocellularity with histiocyte infiltra-
tion and hemophagocytosis, but no evidence of
malignant cells (Fig. 1).
Blood, throat swab, lymph node, and bone mar-
row cultures were negative for bacteria, mycobac-
teria, and fungi. Serological tests were negative
for causative pathogens, including immunoglo-
bulin M (IgM) to viral capsid antigens and
antibodies of the early antigen of the Epstein-Barr
virus, IgM to cytomegalovirus, Herpes simplex
virus, measles, rubella, Toxoplasma gondii, hepatitis
A virus, the core antigen of the hepatitis B virus
(anti-HBc IgM), and antibody to hepatitis C virus.
A rheumatological workup was negative for
antinuclear antibodies and anti-neutrophil
cytoplasmic antibodies. However, the patient's
serum was HIV positive when tested by the
enzyme-linked immunosorbent assay (ELISA) for
HIV. An initial Western blot for HIV revealed
antibodies to HIV protein, p24, and gp160 only.
Such results were regarded as indeterminate.
The patient was treated with supportive care
and all of the aberrant clinical features and
abnormal laboratory findings improved gradually.
A second Western blot was repeated two weeks
after the initial Western blot and indicated clearly
positive results with the antibodies to HIV
protein, p24, and gp120/gp160. At that time, the
patient's peripheral blood CD4 cell count was
157/mm
3 (normal 360 - 1,725/mm
3) and the serum
viral load exceeded 1 × 10
9 copies/mL.
We diagnosed the patient with acute HIV
syndrome presenting with HLH. The patient
promptly received highly active antiretroviral
therapy (HAART) with zidovudine, lamivudine,
and indinavir. No HLH recurrences have occurred
Fig. 1. Microscopic finding of the bone marrow aspiration smear from our patient revealing a marked hemophagocytosis
by histiocytes. (A) The large arrow indicates the phagocytosis of neutrophils and platelets by benign histiocytes (Wright's
stain, × 1,000). (B) Arrowheads indicate hemophagocytes (Wright's stain, × 200).
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since then and the patient has remained well and
free of any opportunistic infections for 3 years.
DISCUSSION
Hemophagocytic lymphohistiocytosis is a rare
disease resulting from the abnormal proliferation
of histiocytes in tissues and organs. According to
the HLH-2004 protocol, the diagnosis of HLH is
established if five out of eight diagnostic criteria
are met. These criteria include five initial criteria
[i) fever, ii) splenomegaly, iii) bicytopenia (with at
least two of the following: hemoglobin 9 g/dL,
platelets < 100 × 10
3/ L, and neutrophils < μ 1.0 ×
10
3/ L in the peripheral blood), iv) hypertrigly μ -
ceridemia ( 265 mg/dL) or hypofibrinogenemia
( 150 mg/dL), and v) hemophagocytosis in the
bone marrow, spleen, or lymph nodes without
evidence of malignancy] and three new criteria
[vi) low or absent NK-cell activity, vii) hyperfer-
ritinemia ( 500 g/L), and viii) increased soluble μ
plasma CD25-levels (IL-2R chain; α 2,400 U/
mL)].
5 Our patient had fever, bicytopenia, hyper-
triglyceridemia, and hyperferritinemia, suggesting
a diagnosis of HLH. The presence of hemophago-
cytosis was subsequently confirmed from bone
marrow specimens. Our patient had no significant
splenomegaly. NK-cell activity and CD25 levels
were not assessed in this patient.
Of the two HLH forms, primary/familial and
secondary/reactive, reactive HLH develops secon-
dary to a variety of viral, bacterial, and parasitic
infections, as well as to malignancy, various auto-
immune diseases, and drug use. To determine the
etiology of HLH in our patient, we performed
imaging studies and a variety of cultures and
serological tests for a number of pathogens and
rheumatological markers. Despite an exhaustive
workup, the HLH could not be attributed to any
associated disorder except for the HIV infection.
In this patient, the initial Western blot for HIV did
not confirm HIV infection, while a follow-up
Western blot 2 weeks later was clearly positive.
Hemophagocytic lymphohistiocytosis has been
diagnosed with increasing frequency in patients
infected with HIV.
2,3 Hemophagocytosis is com-
monly found, to varying degrees, in the bone
marrow of HIV-infected individuals without an
underlying diagnosis of HLH, which raises the
possibility of a subclinical form of HLH.
6 An
autopsy study of 56 patients with acquired immu-
nodeficiency syndrome (AIDS) found an approxi-
mate 20% prevalence of hemophagocytosis.
7 In
fact, most of the reported cases of HLH have been
diagnosed during the advanced stages of HIV
infection, when the patients also suffer from
opportunistic infections and malignancies. Recent
reports have suggested that HLH is a manifes-
tation of acute HIV infection.
8 Although rare,
eight cases of HLH during the acute phase of HIV
infection have been reported. Our case further
confirms that HLH occurs during the seroconver-
sion stage of acute HIV infection.
A recovery rate of 21% (6 out of 28) has been
observed in patients with advanced HIV and
concomitant HLH with opportunistic infections or
malignancies.
9 Nearly 50% of the deaths occurred
within 1 month after the diagnosis of HLH. How-
ever, all nine cases of HLH that were associated
with acute HIV infections recovered, including
our patient.
8,10 Of the eight reported cases with an
HLH diagnosis, four patients received immuno-
modulating agents, such as intravenous immuno-
globulin or steroids. However, the benefit of these
agents for treating HLH associated with acute
HIV infection remains unclear.
8 The signs and
symptoms of HLH in our patient resolved spon-
taneously without any immunomodulating
therapy. This was similar to the findings of three
other reported cases. These findings suggest that
HLH associated with acute HIV infection has a
favorable prognosis compared to when HLH oc-
curs during the advanced stages of HIV infection.
Genetic defects in patients with primary HLH
consist of mutations in the genes required for
cytotoxic granule release or function. However,
the reason why secondary HLH occurs in re-
sponse to infectious organisms, malignancy, or
autoimmune disease remains unclear.
11 The com-
mon pathophysiological abnormality in HLH
patients is cytokine dysfunction, which results in
the uncontrolled accumulation of activated T-
lymphocytes and histiocytes in many organs.
12
Norris et al. reported that cytokine alteration
occurred within 7 days of detectable HIV-1
viremia.
13 Although the plasma cytokine levels
were not measured in our patient, we surmiseKyung-Hwa Park, et al.
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that such early cytokine alterations, from a burst
of viremia associated with acute HIV infection,
were responsible for the HLH in our patient. Even
though a patient with advanced HIV infection and
HLH, who did not respond to HAART, has also
been described,
14 Castilletti et al. showed that
HAART was very effective in controlling both the
acute HIV infection and HLH.
10 Therefore, unlike
in patients with advanced AIDS, the precipitous
decline in plasma viremia during antibody sero-
conversion may explain the more favorable
outcome in patients with acute HIV infection.
Since the recognition of the AIDS epidemic in
1981, the number of patients infected with HIV
has increased dramatically worldwide. As the
number of newly infected HIV patients has
increased recently in Korea, so has the number of
cases with acute HIV syndrome.
15-17 This paper
describes the first report of acute HIV syndrome
presenting as virus-associated HLH in Korea. This
patient recovered spontaneously, without any
immunomodulating therapy. Therefore, acute HIV
syndrome should be considered in the differential
diagnosis of HLH, especially in patients with any
HIV risk factors. In such cases, the appropriate
diagnostic evaluation should be performed.
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